Quality and Cost Outcomes of Clinical Pharmacist Interventions in a Capitated Senior Drug Benefit Plan

Bieszk, Nella

doi:10.18553/jmcp.2002.8.2.124

Cited by 6 publications

(4 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…6 Pharmacist-initiated medication review followed by a recommendation has been shown to lower prescription cost and volume in a Medicare managed care population. 10 An education program was shown to decrease the use of psycho-Impact on Drug Costs and Utilization of a Clinical Pharmacist in a Multisite Primary Care Medical Group Impact on Drug Costs and Utilization of a Clinical Pharmacist in a Multisite Primary Care Medical Group active drugs in a long-term care population. 11 An intervention to decrease the use of inappropriate dipyridamole for cardiovascular disease prophylaxis found that more patients had their dipyridamole prescription discontinued when an educational letter was sent to physicians and pharmacists compared with patients who had a letter sent only to their physician or only to their pharmacist.…”

Section: Ss Discussionmentioning

confidence: 99%

Impact on Drug Costs and Utilization of a Clinical Pharmacist in a Multisite Primary Care Medical Group

Walker¹,

Willey²

2004

JMCP

View full text Add to dashboard Cite

show abstract

Section: Ss Discussionmentioning

confidence: 99%

Impact on Drug Costs and Utilization of a Clinical Pharmacist in a Multisite Primary Care Medical Group

Walker¹,

Willey²

2004

JMCP

View full text Add to dashboard Cite

show abstract

“…A recent study by Bieszk et al used published guidelines for chronic disease management, including hypertension, diabetes, and congestive heart failure as a basis to develop a medication regimen review process to improve quality of care and reduce polypharmacy. 18 Guidelines for prescribing in the elderly, such as the list of inappropriate medications that was developed by Beers with a panel of experts, 19 could have a role similar to chronic disease management guidelines. Instead of focusing on a disease, this set of guidelines, like the pilot study described in this paper, focuses on medication use among a population.…”

Section: ■■ Discussionmentioning

confidence: 99%

A Pharmacist-based Screening Program of Octogenarians Starting New Medications

Seevak

Kent

Wagner

2003

JMCP

View full text Add to dashboard Cite

OBJECTIVE: To measure the impact of clinical pharmacists in primary care practices who closely monitor patients older than 80 years after initiation of new medications. METHODS:The study was an uncontrolled pilot trial performed at a group-model health maintenance organization in the Pacific Northwest between August and December 1999. Forty-eight patients who were older than 80 years and were prescribed at least one new medication in their primary care clinic were called at home 3 to 6 days after starting a new medication and asked questions focusing on compliance and potential adverse drug events.RESULTS: More than 20% of patients (10 of 48) had a clinically important change made as a result of the pharmacist telephone monitoring; 42% of patients (20 of 48) either experienced an undesired medication effect (14 of 48) or an inadequate effect (6 of 48). Pharmacists spent an average 11.3 minutes at an estimated cost of $6.40 per patient.CONCLUSION: A simple, inexpensive pharmacist-based program to screen for medication problems after initiation of new medicines may improve the care to a population older than 80 years.

show abstract

“…Clinical pharmacy services are a mainstay of hospital and managed care pharmacy, and these services have shown benefits in reducing medication errors, decreasing health costs and improving patient care. 5,6 In addition, immunizations have become a standard of practice in pharmacies across the nation. 3,4 The 2011 report from the U.S.…”

Section: ■■ Breaking Down Barriers To Advanced Pharmacy Practicementioning

confidence: 99%